🎉 M&A multiples are live!
Check it out!

PeptiDream Valuation Multiples

Discover revenue and EBITDA valuation multiples for PeptiDream and similar public comparables like Pharming, Armata Pharmaceuticals, and Vivoryon Therapeutics.

PeptiDream Overview

About PeptiDream

PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.


Founded

2006

HQ

Japan
Employees

83

Website

peptidream.com

Financials

LTM Revenue $305M

LTM EBITDA $141M

EV

$1.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

PeptiDream Financials

As of September 2025, PeptiDream reported last 12-month revenue of $305M and EBITDA of $141M.

In the same period, PeptiDream generated $223M in LTM gross profit and $104M in net income.

See PeptiDream valuation multiples based on analyst estimates

PeptiDream P&L

In the most recent fiscal year, PeptiDream reported revenue of $306M and EBITDA of $156M.

PeptiDream expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See PeptiDream valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $305M XXX $306M XXX XXX XXX
Gross Profit $223M XXX $226M XXX XXX XXX
Gross Margin 73% XXX 74% XXX XXX XXX
EBITDA $141M XXX $156M XXX XXX XXX
EBITDA Margin 46% XXX 51% XXX XXX XXX
EBIT $134M XXX $139M XXX XXX XXX
EBIT Margin 44% XXX 45% XXX XXX XXX
Net Profit $104M XXX $98.5M XXX XXX XXX
Net Margin 34% XXX 32% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

PeptiDream Stock Performance

PeptiDream has current market cap of JPY 214B (or $1.4B), and EV of JPY 199B (or $1.3B).

Market Cap Evolution

PeptiDream Stock Data

As of October 17, 2025, PeptiDream's stock price is JPY 1652 (or $11).

See PeptiDream trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.3B $1.4B XXX XXX XXX XXX $0.72

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

PeptiDream Valuation Multiples

PeptiDream's trades at 4.3x EV/Revenue multiple, and 8.3x EV/EBITDA.

See valuation multiples for PeptiDream and 15K+ public comps

PeptiDream Financial Valuation Multiples

As of October 17, 2025, PeptiDream has market cap of $1.4B and EV of $1.3B.

Equity research analysts estimate PeptiDream's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

PeptiDream has a P/E ratio of 13.4x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $1.4B XXX $1.4B XXX XXX XXX
EV (current) $1.3B XXX $1.3B XXX XXX XXX
EV/Revenue 4.3x XXX 4.3x XXX XXX XXX
EV/EBITDA 9.2x XXX 8.3x XXX XXX XXX
EV/EBIT 9.7x XXX 9.4x XXX XXX XXX
EV/Gross Profit 5.8x XXX n/a XXX XXX XXX
P/E 13.4x XXX 14.2x XXX XXX XXX
EV/FCF 13.6x XXX 9.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get PeptiDream Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

PeptiDream Margins & Growth Rates

PeptiDream's last 12 month revenue growth is -1%

PeptiDream's revenue per employee in the last FY averaged $3.7M, while opex per employee averaged $1.1M for the same period.

PeptiDream's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

PeptiDream's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for PeptiDream and other 15K+ public comps

PeptiDream Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth -1% XXX -1% XXX XXX XXX
EBITDA Margin 46% XXX 51% XXX XXX XXX
EBITDA Growth -10% XXX 53% XXX XXX XXX
Rule of 40 30% XXX 50% XXX XXX XXX
Bessemer Rule of X XXX XXX 43% XXX XXX XXX
Revenue per Employee XXX XXX $3.7M XXX XXX XXX
Opex per Employee XXX XXX $1.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 9% XXX XXX XXX
Opex to Revenue XXX XXX 29% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

PeptiDream Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

PeptiDream M&A and Investment Activity

PeptiDream acquired  XXX companies to date.

Last acquisition by PeptiDream was  XXXXXXXX, XXXXX XXXXX XXXXXX . PeptiDream acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by PeptiDream

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About PeptiDream

When was PeptiDream founded? PeptiDream was founded in 2006.
Where is PeptiDream headquartered? PeptiDream is headquartered in Japan.
How many employees does PeptiDream have? As of today, PeptiDream has 83 employees.
Who is the CEO of PeptiDream? PeptiDream's CEO is Mr. Patrick C. Reid.
Is PeptiDream publicy listed? Yes, PeptiDream is a public company listed on TKS.
What is the stock symbol of PeptiDream? PeptiDream trades under 4587 ticker.
When did PeptiDream go public? PeptiDream went public in 2013.
Who are competitors of PeptiDream? Similar companies to PeptiDream include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of PeptiDream? PeptiDream's current market cap is $1.4B
What is the current revenue of PeptiDream? PeptiDream's last 12 months revenue is $305M.
What is the current revenue growth of PeptiDream? PeptiDream revenue growth (NTM/LTM) is -1%.
What is the current EV/Revenue multiple of PeptiDream? Current revenue multiple of PeptiDream is 4.3x.
Is PeptiDream profitable? Yes, PeptiDream is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of PeptiDream? PeptiDream's last 12 months EBITDA is $141M.
What is PeptiDream's EBITDA margin? PeptiDream's last 12 months EBITDA margin is 46%.
What is the current EV/EBITDA multiple of PeptiDream? Current EBITDA multiple of PeptiDream is 9.2x.
What is the current FCF of PeptiDream? PeptiDream's last 12 months FCF is $96.1M.
What is PeptiDream's FCF margin? PeptiDream's last 12 months FCF margin is 31%.
What is the current EV/FCF multiple of PeptiDream? Current FCF multiple of PeptiDream is 13.6x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.